Clostridium difficile Vaccine and Serum Immunoglobulin G Antibody Response to Toxin A
Open Access
- 1 March 2003
- journal article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 71 (3) , 1608-1610
- https://doi.org/10.1128/iai.71.3.1608-1610.2003
Abstract
There is a strong association between serum antibody responses to toxin A and protection against Clostridium difficile diarrhea. A parenteral C. difficile toxoid vaccine induced very-high-level responses to anti-toxin A immunoglobulin G (IgG) in the sera of healthy volunteers. After vaccination, the concentrations of anti-toxin A IgG in the sera of all 30 recipients exceeded the concentrations that were associated with protection in previous clinical studies. Furthermore, the median concentration of serum anti-toxin A IgG in the test group was 50-fold higher than the previous threshold. These findings support the feasibility of using a vaccine to protect high-risk individuals against C. difficile-associated diarrhea and colitis.Keywords
This publication has 28 references indexed in Scilit:
- Antibiotic-Associated DiarrheaNew England Journal of Medicine, 2002
- Clostridium difficileGastroenterology Clinics of North America, 2001
- Safety and Immunogenicity of Increasing Doses of a Clostridium difficile Toxoid Vaccine Administered to Healthy AdultsInfection and Immunity, 2001
- Toxin Gene Analysis of a Variant Strain of Clostridium difficile That Causes Human Clinical DiseaseInfection and Immunity, 2000
- Asymptomatic Carriage ofClostridium difficileand Serum Levels of IgG Antibody against Toxin ANew England Journal of Medicine, 2000
- Immune response to Clostridium difficile infectionEuropean Journal of Gastroenterology & Hepatology, 1996
- Clostridium difficile toxin B is more potent than toxin A in damaging human colonic epithelium in vitro.Journal of Clinical Investigation, 1995
- Systemic and Mucosal Antibody Responses to Toxin A in Patients Infected with Clostridium difficileThe Journal of Infectious Diseases, 1992
- Treatment with intravenously administered gamma globulin of chronic relapsing colitis induced by Clostridium difficile toxinThe Journal of Pediatrics, 1991
- Nosocomial Acquisition ofClostridium difficileInfectionNew England Journal of Medicine, 1989